Literature DB >> 32075431

Telmisartan improves myocardial remodeling by inhibiting leptin autocrine activity and activating PPARγ.

Hui Chen1, Min Li1,2, Lei Liu1, Danjun Zhu1, Gang Tian1.   

Abstract

Entities:  

Keywords:  Hypertensive left ventricular hypertrophy; angiotensin II; autocrine; leptin; myocardial remodeling; telmisartan

Mesh：

Substances：

Year:  2020        PMID： 32075431      PMCID： PMC7153214          DOI： 10.1177/1535370220908215

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  41 in total

1.  Effect of telmisartan on the regression of the left ventricular hypertrophy in the patients of essential hypertension.

Authors:  Kumar Haraprasad Misra; Mangala Charana Das; Y Roja Ramani
Journal:  J Clin Diagn Res       Date:  2013-07-01

2.  Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes.

Authors:  Siham Madani; Sabrina De Girolamo; Diana Marcela Muñoz; Ren-Ke Li; Gary Sweeney
Journal:  Cardiovasc Res       Date:  2005-12-22       Impact factor: 10.787

3.  Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension.

Authors:  P Verdecchia; G Reboldi; G Schillaci; C Borgioni; A Ciucci; M P Telera; F Santeusanio; C Porcellati; P Brunetti
Journal:  Circulation       Date:  1999-10-26       Impact factor: 29.690

4.  Leptin induces hypertrophy through activating the peroxisome proliferator-activated receptor α pathway in cultured neonatal rat cardiomyocytes.

Authors:  Ning Hou; Miao-Shan Luo; Shi-Ming Liu; Hai-Ning Zhang; Qing Xiao; Pu Sun; Gen-Shui Zhang; Jian-Dong Luo; Min-Sheng Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-11       Impact factor: 2.557

Review 5.  Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.

Authors:  R M Touyz; E L Schiffrin
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

6.  Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure.

Authors:  Takuya Kishi; Yoshitaka Hirooka; Kenji Sunagawa
Journal:  Am J Hypertens       Date:  2013-10-05       Impact factor: 2.689

7.  Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy.

Authors:  Karin Malmqvist; Håkan N Wallén; Claes Held; Thomas Kahan
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

8.  Angiotensin II and the ERK pathway mediate the induction of leptin by mechanical cyclic stretch in cultured rat neonatal cardiomyocytes.

Authors:  Chiung-Zuan Chiu; Bao-Wei Wang; Kou-Gi Shyu
Journal:  Clin Sci (Lond)       Date:  2014-04       Impact factor: 6.124

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling.

Authors:  Danny Ben-Zvi; Naphtali Savion; Frank Kolodgie; Amos Simon; Sudeshna Fisch; Katrin Schäfer; Noa Bachner-Hinenzon; Xin Cao; Arieh Gertler; Gili Solomon; Erez Kachel; Ehud Raanani; Jacob Lavee; Shlomo Kotev Emeth; Renu Virmani; Frederick J Schoen; Jacob Schneiderman
Journal:  J Am Heart Assoc       Date:  2016-05-03       Impact factor: 5.501
View more
  5 in total

Review 1.  Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity-Pathogenesis and Involvement of the Extracellular Matrix.

Authors:  Jagoda Kruszewska; Agnieszka Cudnoch-Jedrzejewska; Katarzyna Czarzasta
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

2.  Telmisartan Mitigates TNF-α-Induced Type II Collagen Reduction by Upregulating SOX-9.

Authors:  Xiuying Zhang; Yanfeng Dong; Hanyu Dong; Yanhui Cui; Qing Du; Xiaoli Wang; Lanlan Li; Hongju Zhang
Journal:  ACS Omega       Date:  2021-04-22

Review 3.  Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.

Authors:  Gashaw Dessie; Birhanu Ayelign; Yonas Akalu; Tewodros Shibabaw; Meseret Derbew Molla
Journal:  Diabetes Metab Syndr Obes       Date:  2021-07-17       Impact factor: 3.168

4.  Hyperleptinemia results in systemic inflammation and the exacerbation of ischemia-reperfusion myocardial injury.

Authors:  Ekaterina A Polyakova; Evgeny N Mikhaylov; Michael M Galagudza; Evgeny V Shlyakhto
Journal:  Heliyon       Date:  2021-11-26

5.  Pericardial Adipose Tissue-Derived Leptin Promotes Myocardial Apoptosis in High-Fat Diet-Induced Obese Rats Through Janus Kinase 2/Reactive Oxygen Species/Na+/K+-ATPase Signaling Pathway.

Authors:  Ping Wang; Chaodi Luo; Danjun Zhu; Yan Song; Lifei Cao; Hui Luan; Lan Gao; Shuping Zheng; Hao Li; Gang Tian
Journal:  J Am Heart Assoc       Date:  2021-09-06       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.